These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19043379)

  • 1. Liposomal methotrexate hydrogel for treatment of localized psoriasis: preparation, characterization and laser targeting.
    Ali MF; Salah M; Rafea M; Saleh N
    Med Sci Monit; 2008 Dec; 14(12):PI66-74. PubMed ID: 19043379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy study of vesicular gel containing methotrexate and menthol combination on parakeratotic rat skin model.
    Nagle A; Goyal AK; Kesarla R; Murthy RR
    J Liposome Res; 2011 Jun; 21(2):134-40. PubMed ID: 20557280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
    Eskicirak B; Zemheri E; Cerkezoglu A
    Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment.
    Srisuk P; Thongnopnua P; Raktanonchai U; Kanokpanont S
    Int J Pharm; 2012 May; 427(2):426-34. PubMed ID: 22310459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal methylene blue hydrogel for selective photodynamic therapy of acne vulgaris.
    Fadel M; Salah M; Samy N; Mona S
    J Drugs Dermatol; 2009 Nov; 8(11):983-90. PubMed ID: 19894365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate treatment in 13 children with severe plaque psoriasis.
    Collin B; Vani A; Ogboli M; Moss C
    Clin Exp Dermatol; 2009 Apr; 34(3):295-8. PubMed ID: 19175782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical treatment of psoriatic skin with methotrexate cream: a clinical, pharmacokinetic, and histological study.
    Bjerring P; Beck HI; Zachariae H; Søgaard H
    Acta Derm Venereol; 1986; 66(6):515-9. PubMed ID: 2433872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of topical delivery of methotrexate by electroporation.
    Wong TW; Zhao YL; Sen A; Hui SW
    Br J Dermatol; 2005 Mar; 152(3):524-30. PubMed ID: 15787822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial.
    Ormerod AD; Shah SA; Copeland P; Omar G; Winfield A
    Br J Dermatol; 2005 Apr; 152(4):758-64. PubMed ID: 15840110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylene blue mediated photodynamic therapy for resistant plaque psoriasis.
    Salah M; Samy N; Fadel M
    J Drugs Dermatol; 2009 Jan; 8(1):42-9. PubMed ID: 19180895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Topical Gel of Methotrexate Incorporated Ethosomes and Salicylic Acid for the Treatment of Psoriasis.
    Chandra A; Aggarwal G; Manchanda S; Narula A
    Pharm Nanotechnol; 2019; 7(5):362-374. PubMed ID: 31490769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: a placebo-controlled, double-blind study.
    Syed TA; Hadi SM; Qureshi ZA; Nordstrom CG; Ali SM
    J Cutan Med Surg; 2001; 5(4):299-302. PubMed ID: 11907839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niosomal methotrexate gel in the treatment of localized psoriasis: phase I and phase II studies.
    Lakshmi PK; Devi GS; Bhaskaran S; Sacchidanand S
    Indian J Dermatol Venereol Leprol; 2007; 73(3):157-61. PubMed ID: 17558046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical delivery of methotrexate via skin pretreated with physical enhancement techniques: low-fluence erbium:YAG laser and electroporation.
    Lee WR; Shen SC; Fang CL; Zhuo RZ; Fang JY
    Lasers Surg Med; 2008 Sep; 40(7):468-76. PubMed ID: 18727021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical methotrexate therapy for psoriasis.
    Weinstein GD; McCullough JL; Olsen E
    Arch Dermatol; 1989 Feb; 125(2):227-30. PubMed ID: 2913960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing percutaneous delivery of methotrexate using different types of surfactants.
    Javadzadeh Y; Hamishehkar H
    Colloids Surf B Biointerfaces; 2011 Feb; 82(2):422-6. PubMed ID: 20951009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery and formulations for the topical treatment of psoriasis.
    Su YH; Fang JY
    Expert Opin Drug Deliv; 2008 Feb; 5(2):235-49. PubMed ID: 18248321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate for the treatment of adult atopic dermatitis.
    Goujon C; Bérard F; Dahel K; Guillot I; Hennino A; Nosbaum A; Saad N; Nicolas JF
    Eur J Dermatol; 2006; 16(2):155-8. PubMed ID: 16581567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased insulin-like growth factor binding protein-3 expression level in psoriatic tissue before and after systemic treatment with cyclosporine A and methotrexate.
    Ozden MG; Ilter N; Suer OE; Solaktekin N; Gürer MA
    Int J Dermatol; 2008 Nov; 47(11):1177-83. PubMed ID: 18986456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.